stockrow
Friday 6 November 2026
Export OMDA’s income statement to Excel — free account
Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024.
- Revenue
- +34.2%
- EPS
- +283.3%
- Free cash flow
- +65.8%
Quarter to September 2026, against a year earlier
15.10
3.85
−20.32%
Follow OMDA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+7 more quarters Free account |
0.00 | 0.00 | 313.57 | 86.71 |
P/S ratio |
2.22 | 2.61 | 4.23 | 3.84 | |
P/FCF ratio |
46.55 | 45.17 | 76.47 | 56.90 | |
P/Operating CF |
27.04 | (62.59) | 326.95 | 84.53 | |
P/B ratio |
2.52 | 3.16 | 5.18 | 4.69 | |
Price to Tangible BV |
2.70 | 3.38 | 5.51 | 4.95 | |
EV/Sales |
1.48 | 1.97 | 3.61 | 3.20 | |
EV/EBITDA |
0.00 | 533.27 | 121.98 | 116.34 | |
EV/Operating CF |
21.15 | 24.80 | 47.22 | 37.17 | |
EV/FCF |
31.09 | 34.09 | 65.28 | 47.42 | |
Quick Ratio |
3.39 | 3.67 | 3.69 | 3.87 | |
Current Ratio |
3.60 | 3.92 | 3.91 | 4.18 | |
Net Debt/EBITDA |
(39.65) | 91.48 | (36.36) | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.70 | 1.87 | 0.98 | 1.05 | |
Operating CF/Net income |
4.14 | 3.98 | 0.76 | 2.31 | |
Capex/Depreciation |
(0.58) | (0.63) | (0.65) | 0.00 | |
Interest Coverage |
252.38 | (265.61) | 253.50 | 18.40 | |
Research and Development Expense of Revenue |
15.23% | 16.27% | 16.65% | 16.73% | |
Selling, General and Administrative Expense of Revenue |
51.19% | 52.25% | 51.93% | 0.00% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.05 | 0.04 | |
Share Based Compensation of Revenue |
4.94% | 5.39% | 6.41% | 6.41% | |
Graham Net Nets |
0.34 | 0.27 | 0.17 | 0.19 | |
Graham Number |
0.00 | 0.00 | 2.58 | 4.90 | |
Earnings Yield |
(8.60%) | (2.07%) | 0.32% | 1.15% | |
Free Cash Flow Yield |
2.15% | 2.21% | 1.31% | 1.76% | |
Revenue per Share |
2.07 | 1.32 | 1.47 | 1.48 | |
Operating CF per Share |
0.58 | (0.20) | 0.07 | 0.25 | |
Capex per Share |
(0.04) | (0.03) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.55 | (0.23) | 0.04 | 0.22 | |
Cash per Share |
6.06 | 3.59 | 3.71 | 3.95 | |
Shareholders Equity per Share |
6.27 | 3.97 | 4.23 | 4.44 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.27 | 3.97 | 4.23 | 4.44 | |
Free Cash Flow |
20.03 | (13.39) | 2.34 | 13.51 | |
Working Capital |
197.21 | 200.75 | 219.43 | 239.68 | |
Capital Expenditures |
(1.35) | (1.56) | (1.66) | (1.63) | |
Net Current Asset Value |
197.21 | 200.75 | 219.43 | 239.68 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 155.28 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 186.31 | |
| Other line items | |||||
Average Receivables |
— | 31.70 | 44.93 | 44.82 | |
Average Payables |
— | 6.13 | 9.60 | 6.86 | |
Average Inventory |
— | 3.56 | 3.79 | 4.01 | |
Average Assets |
152.70 | 151.40 | 315.60 | 318.00 | |
Average Common Equity |
— | (75.14) | 233.48 | 245.22 |
Columns are period end dates · fundamentals updated 6 Nov 2026